Breaking News Instant updates and real-time market news.

CSX

CSX

$79.00

3.14 (4.14%)

, UAL

United Continental

$88.25

3.74 (4.43%)

19:04
04/16/19
04/16
19:04
04/16/19
19:04

Fly Intel: After Hours Movers

UP AFTER EARNINGS: CSX Corp (CSX) up 4.1%... United Continental (UAL ) up 3.3%. ALSO HIGHER: Qualcomm (QCOM) up 5.5% on Apple litigation settlement momentum, Stifel upgrade... Teladoc (TDOC) up 1.8% after being initiated with Overweight at Stephens. DOWN AFTER EARNINGS: IBM (IBM) down 2.7%... Hancock Whitney (HWC) down 1.5%... Netflix (NFLX) down 1.2%... United Financial Bancorp (UBNK) down 0.5%. ALSO LOWER: Sprint (S) down 7.0%, T-Mobile (TMUS) down 4% after WSJ report suggesting their merger is unlikely to be approved by DoJ as currently structured... Natera (NTRA) down 6.7% after equity offering... Arconic (ARNC) down 1.9% after 8.7M share block trade indicated price range below close. Movers as of 18:45ET.

CSX

CSX

$79.00

3.14 (4.14%)

UAL

United Continental

$88.25

3.74 (4.43%)

QCOM

Qualcomm

$74.25

17.06 (29.83%)

TDOC

Teladoc

$53.13

-0.94 (-1.74%)

IBM

IBM

$141.00

-2.98 (-2.07%)

HWC

Hancock Whitney

$44.48

1.1 (2.54%)

NFLX

Netflix

$354.32

5.44 (1.56%)

UBNK

United Financial

$14.92

0.09 (0.61%)

S

Sprint

$5.57

-0.31 (-5.27%)

TMUS

T-Mobile

$71.00

-2.8 (-3.79%)

NTRA

Natera

$20.00

-0.27 (-1.33%)

ARNC

Arconic

$20.56

0.02 (0.10%)

  • 16

    Apr

  • 16

    Apr

  • 16

    Apr

  • 17

    Apr

  • 17

    Apr

  • 17

    Apr

  • 17

    Apr

  • 24

    Apr

  • 30

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 13

    May

  • 13

    May

  • 14

    May

  • 16

    May

  • 28

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

  • 17

    Apr

  • 18

    Apr

CSX CSX
$79.00

3.14 (4.14%)

03/06/19
03/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. TripAdvisor (TRIP) downgraded to Underperform from Market Perform at Cowen with analyst Kevin Kopelman citing a weak start to 2019, expectations for weaker usage, and worries about younger age demos using Google (GOOG). 2. Teva (TEVA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger citing his belief that the stock's premium valuation largely prices in expectations for upside in the coming quarters due to cost cutting and conservative Copaxone guidance. 3. VMware (VMW) downgraded to Sell from Neutral at Goldman Sachs, while Pivotal Software (PVTL) was downgraded to Neutral from Buy. 4. Ormat Technologies (ORA) downgraded to Neutral from Overweight at JPMorgan with the firm's analyst citing a lack of catalysts for share appreciation in 2019. 5. CSX (CSX) downgraded to Hold from Buy at Stifel with analyst Michael Baudendistel saying he no longer sees a solid reason why shares should outperform the market in the next twelve months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/19
STFL
03/06/19
DOWNGRADE
Target $74
STFL
Hold
CSX downgraded to Hold from Buy at Stifel
Stifel analyst Michael Baudendistel downgraded CSX to Hold from Buy as he no longer sees a solid reason why shares should outperform the market in the next twelve months. In 2018, "most everything went right and then some" for CSX and he sees that as unlikely to fully repeat in 2019, Baudendistel tells investors. The analyst, who believes CSX has the lowest revenue growth potential in the next two years among railroads he covers, keeps a $74 price target on the shares.
04/05/19
UBSW
04/05/19
DOWNGRADE
Target $80
UBSW
Neutral
CSX downgraded to Neutral from Buy at UBS
UBS analyst Thomas Wadewitz downgraded CSX to Neutral from Buy while raising his price target for the shares to $80 from $75. The stock, after performing strongly on a multi-year basis and also in 2019, now reflects the good news in terms of further margin improvement and "industry leading" operating ratio performance, Wadewitz tells investors in a research note. The analyst believes CSX's reward/risk is no longer skewed to the upside at current share levels.
04/03/19
SUSQ
04/03/19
DOWNGRADE
SUSQ
Neutral
CSX downgraded to Neutral from Positive at Susquehanna
UAL United Continental
$88.25

3.74 (4.43%)

03/13/19
MSCO
03/13/19
NO CHANGE
MSCO
Morgan Stanley says 737 MAX grounding shouldn't hurt long-term fundamentals
Morgan Stanley analyst Rajeev Lalwani noted that most major countries and airlines that operate Boeing's (BA) 737 MAX, except for the U.S. and Canada, have placed restrictions around the plane and his expectation is for a grounding of the fleet globally. In that base case, he said there is likely to be disruption to Boeing's deliveries and order activity that ultimately create a buying opportunity over the coming quarters as he thinks the issue should not impact fundamentals in the long run. In regard to suppliers such as Spirit AeroSystems (SPR) and United Technologies (UTX), Lalwani believes disruption will be limited, contrary to market reactions. Among U.S. airlines who operate the 737 MAX, Lalwani said Southwest (LUV) screens as most exposed versus American Airlines (AAL) and United Continental (UAL). For aircraft lessors like Air Lease (AL) and AerCap (AER), a global grounding scenario has "mixed implications," added the analyst. Though he remains comfortable with his Overweight rating and $500 price target on Boeing shares, Lalwani thinks clarity on the path ahead for the 737 will be needed for shares to resume their upward trend.
03/15/19
IMPC
03/15/19
NO CHANGE
Target $78
IMPC
Underperform
United Continental shares offer unfavorable risk/reward, says Imperial Capital
Imperial Capital analyst Michael Derchin says shares of United Continental Holdings (UAL) offer an unfavorable risk/reward opportunity at current levels. United's unit revenue momentum is likely to slow meaningfully and possibly inflect to negative territory by the second half of 2019, Derchin tells investors in a research note. The shares are trading at nearly a 40% premium to American Airlines (AAL) on fiscal 2020 earnings estimates despite relatively similar margin outlooks, adds the analyst. He keeps an Underperform rating on United Continental with a $78 price target.
03/01/19
DBAB
03/01/19
DOWNGRADE
DBAB
Hold
Deutsche downgrades American Airlines, Delta on global market exposure
Deutsche Bank analyst Michael Linenberg downgraded both American Airlines (AAL) and Delta Air Lines (DAL) to Hold from Buy. Recent global macro data points "have been less encouraging of late" suggesting that airline industry risks are now more biased to the downside, Linenberg tells investors in a research note. As a result, the analyst is finding it more difficult to advocate "new money" positions in names with the most exposure to global markets. This drives his downgrade of both American and Delta to Hold. Linenberg lowered his price target for American to $40 from $47 and for Delta to $55 from $66. He also lowered his target for Buy-rated Alaska Air (ALK) to $73 from $75, for Buy-rated Allegiant Travel (ALGT) to $160 from $169, for Buy-rated JetBlue (JBLU) to $20 from $22, for Buy-rated SkyWest (SKYW) to $68 from $75, for Buy-rated Spirit Airlines (SAVE) to $75 from $79, for United Continental (UAL) to $105 from $109, and for Buy-rated Mesa Air (MESA) to $17 from $18.
04/02/19
SPHN
04/02/19
NO CHANGE
Target $63
SPHN
Overweight
Airlines needed some good news, and Delta delivered, says Stephens
With investor sentiment on the airline space negative, the group was in need of some good news and Delta Air Lines delivered a positive surprise this morning, Stephens analyst Jack Atkins tells investors in a research note. The airline pointed Q1 RASM growth to the upper-end of its initial guidance range, lowered its Q1 CASM excluding fuel expectation and raised its Q1 earnings guidance range, says the analyst. Atkins finds it encouraging that Delta noted underlying passenger demand remains solid and that the business market led the way during the quarter. Further, the company announced an extension of its credit card partnership with American Express (AXP), which is expected to double the revenue contribution to $7B by 2023 versus 2018 levels, he notes. Atkins reiterates an Overweight rating on Delta with a $63 price target. The stock in midday trading is up 7% to $55.64. Other names in the airline space include Alaska Air (ALK), American Airlines (AAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Continental (UAL).
QCOM Qualcomm
$74.25

17.06 (29.83%)

04/16/19
STFL
04/16/19
UPGRADE
STFL
Buy
Qualcomm upgraded to Buy from Hold at Stifel
03/27/19
03/27/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Qualcomm (QCOM) initiated with a Neutral at JPMorgan. 2. Occidental Petroleum (OXY) initiated with a Perform at Oppenheimer. 3. Boeing (BA) resumed with a Buy at Citi. 4. Square (SQ) initiated with an Outperform at Macquarie. 5. Frontdoor (FTDR) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/19
ARGS
04/04/19
NO CHANGE
Target $85
ARGS
Buy
Qualcomm CFO exit immaterial, says Argus
Argus analyst Jim Kelleher is keeping his Buy rating and $85 price target on Qualcomm (QCOM), saying the latest announcement that its CFO George Davis is stepping down to join Intel (INTC) is immaterial and a "side show". The analyst sees the real "main event" risk with the company's upcoming trial this month in a dispute with Apple (AAPL), which has alleged that Qualcomm's licensing model is illegal. Kelleher contends however that Qualcomm's licensing model has "repeatedly been validated" and the company has "withstood multiple legal challenges over the past two decades".
04/16/19
STFL
04/16/19
UPGRADE
Target $100
STFL
Buy
Qualcomm upgraded to Buy from Hold at Stifel
Stifel analyst Kevin Cassidy upgraded Qualcomm (QCOM) to Buy and raised his price target to $100 from $57, saying today's "surprise" agreement with Apple (AAPL) to settle all pending litigation removes a legal overhang that persisted for the past two years. The analyst also contends that the concession made by Apple was designed to make sure that a 5G iPhone would be available in the market in 2020 and may signal that Intel's (INTC) 5G modem "may not be production-ready" next year. Shares of Qualcomm have extended their late session 23% spike on the news with another 5.8% gain afterhours, while Intel is trading down about 0.6%.
TDOC Teladoc
$53.13

-0.94 (-1.74%)

04/01/19
PIPR
04/01/19
NO CHANGE
Target $86
PIPR
Overweight
Teladoc oversold on Aetna contract confusion, says Piper Jaffray
Piper Jaffray analyst Sean Wieland believes some confusion over Aetna's intentions have pressured the shares of Teladoc (TDOC). The confusion lies in the fact that this was a "Request for Price" and not a "Request for Proposal," Wieland tells investors in a research note. However, his channel checks indicate there isn't any intention of CVS Health's (CVS) Aetna switching vendors. To the contrary, we've seen companies do this in front of a contract expansion, when they need to provide the board with benchmark pricing data to prove they are not overpaying, says the analyst. As such, he believes potential risk related to Teladoc's Aetna contract is minimal. Further, Wieland sees upside to Teladoc's initial guidance on stronger utilization trends as "telemedicine continues to go mainstream." He views the stock as oversold and reiterates an Overweight rating with an $86 price target.
04/08/19
PIPR
04/08/19
NO CHANGE
Target $86
PIPR
Overweight
Final CMS rule 'another win' for telemedicine industry, says Piper Jaffray
The Centers for Medicare & Medicaid Services on Friday issued a final that marks "another win" for the telemedicine industry, Piper Jaffray analyst Sean Wieland tell investors in a research note. Beginning 2020, Medicare Advantage plans will cover various telehealth services, including phone/video visits for medical or mental health needs, says the analyst. He believes there is a "strong value proposition" for health plans to promote these services to their beneficiaries, and that Teladoc is well positioned to gain from this trend. Wieland reiterates an Overweight rating on Teladoc shares with an $86 price target.
04/16/19
SPHN
04/16/19
INITIATION
Target $75
SPHN
Overweight
Teladoc initiated with an Overweight at Stephens
Stephens initiated Teladoc with an Overweight and $75 price target.
04/16/19
SPHN
04/16/19
INITIATION
Target $75
SPHN
Overweight
Teladoc initiated with an Overweight at Stephens
Stephens analyst Jacob Johnson initiated Teladoc with an Overweight rating and a price target of $75, saying the company is an "industry leader" in the telehealth industry which is undergoing "considerable growth" that is still in its "early innings". The analyst also notes that any M&A by Teladoc should "increase the value of its platform by adding capabilities and geographies", adding that while its gross margins may decline as a result of a "shifting revenue mix," the company's operating leverage should result in expanding EBITDA margins. Johnson further states that Teladoc shares are not cheap, but still trade "at a discount to high-growth healthcare and tech peers."
IBM IBM
$141.00

-2.98 (-2.07%)

02/11/19
PIPR
02/11/19
NO CHANGE
PIPR
Piper storage survey positive for Pure Storage, Nutanix, NetApp
Piper Jaffray conducted its fiscal Q4 Storage Reseller Survey by collecting feedback from 28 resellers and distributors. While only five of 14 vendors had net positive results versus six of the 14 last quarter, the firm saw "strong results" for Pure Storage (PSTG), Rubrik, Nutanix (NTNX), Veeam and NetApp (NTAP), analyst Andrew Nowinski told investors earlier in a research note. Pure Storage also had the strongest pipeline heading into the April quarter, added the analyst. The company's results sharply improved in the survey, with 67% of resellers citing "Above Plan" results, the highest level seen in three years, says Nowinski. The stock in early trading is up 19c to $18.47. Of those surveyed by Piper, 36% of resellers said they saw a negative impact from the U.S. government shutdown, with Dell (DELL), HP/3PAR (HPQ) and IBM (IMB) the most impacted.
03/26/19
BERN
03/26/19
NO CHANGE
BERN
Red Hat worth $190/share 'even as stand alone entity,' says Bernstein
Bernstein analyst Zane Chrane notes that Red Hat's (RHT) Q4 results are unlikely to have a material impact on the stock price given the expected acquisition by IBM (IBM) in the second half of 2019. However, strong growth in emerging products, continued reacceleration in RHEL revenue, and robust growth in deferred revenue and backlog all suggest the company is having increasing success in cross-selling its hybrid cloud solutions to large enterprise customers, he contends, adding that this quarter's results were "strong across the board," suggesting that the pending IBM deal is not having any negative impact on the company's execution. Chrane believes Red Hat is worth $190 per share "even as a stand-alone entity."
03/15/19
BMOC
03/15/19
DOWNGRADE
Target $53
BMOC
Market Perform
Oracle downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Keith Bachman downgraded Oracle (ORCL) to Market Perform from Outperform with an unchanged price target of $53 following last night's fiscal Q3 results. The stock in premarket trading is down 3%, or $1.65, to $51.40. The analyst believes Oracle can sustain ~2% constant currency revenue growth, but is "dubious" the company can improve its revenue growth rates. He does not think autonomous database or gradual unfolding of the cloud enterprise resource planning market will help Oracle's growth in fiscal 2020. As demonstrated by IBM (IBM) over the years, an aggressive buyback will not be enough to push the shares meaningfully higher without improved top-line results, Bachman tells investors in a post-earnings research note. As such, he sees a balanced risk/reward profile at current share levels.
04/11/19
FBCO
04/11/19
INITIATION
Target $173
FBCO
Outperform
IBM initiated with an Outperform at Credit Suisse
Credit Suisse analyst Matt Cabral initiated IBM (IBM) with an Outperform rating and a price target of $173. The analyst cites the impact of the company's pending Red Hat (RHT) acquisition generating synergies while bringing together the industry expertise and incumbency to "help customers move to hybrid". Cabral adds that while IBM has sustainable free cash flow of about $12B ex-Red Hat, he expects the deal to be cash flow accretive in the first year, becoming the company's "main driver of growth".
HWC Hancock Whitney
$44.48

1.1 (2.54%)

12/06/18
FIGP
12/06/18
UPGRADE
FIGP
Outperform
Hancock Whitney upgraded to Outperform from Market Perform at Fig Partners
08/23/18
JEFF
08/23/18
NO CHANGE
JEFF
Jefferies identifies six potential takeover targets for BB&T
Following BB&T's (BBT) recent bank comments regarding acquisitions and clarifications of its parameters, Jefferies analyst Ken Usdin identified six regional banks as potential takeover targets: BancorpSouth (BXS), First Horizon (FHN), Hancock Whitney (HWC), Iberiabank (IBKC), Pinnacle Financial (PNFP) and United Bankshares (UBSI). First Horizon and Iberiabank "look the best-fitting solely from a number perspective," Usdin tells investors in a research note. The analyst believes BB&T could pay "sizable control premiums" for both, namely 28% Iberiabank and 15% for First Horizon, while achieving earnings accretion in year one.
01/07/19
RAJA
01/07/19
DOWNGRADE
RAJA
Outperform
Hancock Whitney downgraded to Outperform from Strong Buy at Raymond James
07/19/18
SPHN
07/19/18
UPGRADE
Target $59
SPHN
Overweight
Stephens upgrades Hancock Whitney to Overweight on improved credit trends
Stephens analyst Matt Olney upgraded Hancock Whitney to Overweight from Equal Weight and raised his price target for the shares to $59 from $54. The analyst is encouraged by the company's Q2 results due to improved credit trends, lower deposit beta and "continued steady" organic loan growth. He also believes Hancock's updated guidance around core net interest margin and additional credit recovery is positive. Hancock Whitney is unlikely to do a larger dilutive acquisition in the near-term and its deposit franchise is underappreciated, Olney tells investors in a research note.
NFLX Netflix
$354.32

5.44 (1.56%)

04/16/19
DBAB
04/16/19
UPGRADE
DBAB
Buy
Netflix upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft upgraded Netflix to Buy from Hold ahead of tonight's Q1 results.
04/16/19
DBAB
04/16/19
UPGRADE
Target $400
DBAB
Buy
Deutsche Bank upgrades Netflix to Buy, sees $400 stock in 12 months
Deutsche Bank analyst Bryan Kraft upgraded Netflix to Buy from Hold and raised his price target for the shares to $400 from $360. The streaming service, which reports Q1 results after the bell tonight, closed yesterday down $2.27 to $348.87. Consensus subscriber expectations for both 2019 and 2020 now seem conservative, Kraft tells investors in a research note. Further, Netflix shares have "de-rated enough," which makes the risk/reward profile attractive, adds the analyst. He sees the company's growth in revenue taking the stock to $400 over the next 12 months as the valuation shifts from 2019 to 2020 estimates. Netflix is winning the battle for talent and "looking more and more like a platform every day, rather than just an application," according to Kraft.
04/16/19
BMOC
04/16/19
NO CHANGE
Target $470
BMOC
Outperform
Netflix price target raised to $470 from $440 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Netflix (NFLX) to $470 and kept his Outperform rating ahead of its Q1 earnings today, saying he expects "strong results" from the company. The analyst bases his price target change on his rolled out estimates for 2021-2028 and believes that Netflix still has "room to grow" internationally - particularly in India and Japan - while improving its per subscriber leverage on content spend and generating "steady growth of its consumer product licensing revenues." Salmon also believes that while Netflix remains the clear leader in global streaming, Amazon (AMZN) and Disney (DIS) can also be "long-term winners" in the sector.
04/16/19
04/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft saying consensus subscriber expectations for both 2019 and 2020 now seem conservative. 2. Cenovus Energy (CVE) upgraded to Neutral from Sell at Goldman Sachs with analyst Neil Mehta citing improvements to the company's leverage outlook and a more constructive commodity price environment, particularly for Canadian heavy crude. 3. Cummins (CMI) upgraded to Buy from Neutral at Citi with analyst Timothy Thein saying he sees upside to 2019 estimates and thinks the company's out-year cash flows "stay higher for longer based on end market diversity and increasing contribution from the aftermarket." 4. Western Digital (WDC) upgraded to Buy from Hold at Deutsche Bank with analyst Sidney Ho starting to see favorable data points in both hard disk drive and NAND that will support a "solid" second half of the year recovery for Western Digital's earnings. 5. e.l.f. Beauty (ELF) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UBNK United Financial
$14.92

0.09 (0.61%)

S Sprint
$5.57

-0.31 (-5.27%)

02/28/19
02/28/19
DOWNGRADE

Perform
American Tower downgraded to Perform on valuation at Oppenheimer
As previously reported, Oppenheimer analyst Timothy Horan downgraded American Tower (AMT) to Perform from Outperform on valuation. The analyst notes that the stock is up 19.5% since his wireless tower outlook published in early October, while Crown Castle (CCI) is up only 7.5%. While Horan acknowledges that American Tower's fundamentals are strong and the company is well positioned for growth, he believes there are near-term concerns. India churn brings volatility into the model, rising rates are a risk, as is the Spring (S)/T-Mobile (TMUS) merger and forex, he contends.
04/15/19
04/15/19
DOWNGRADE
Target $196

Market Perform
American Tower downgraded to Market Perform on valuation at Wells Fargo
As previously reported, Wells Fargo analyst Jennifer Fritzsche downgraded American Tower (AMT) to Market Perform from Outperform, while raising her price target on the shares to $196 from $190. The analyst notes that the stock is up 25%-plus year to data. Furthermore, Fritzsche remains concerned about headwinds on the international side of its business as well as 2019 guidance, which likely will not fall into the normal "beat and raise" story it has seen in the past given somewhat of a holding pattern of spending by carriers in the U.S. Additionally, while the outcome of the looming Sprint (S)/T-Mobile (TMUS) merger could impact the group overall, American Tower's valuation could be more impacted given its strong performance year to date, she contends.
02/12/19
KEYB
02/12/19
NO CHANGE
Target $195
KEYB
Overweight
SBA Communications price target raised to $195 from $183.97 at KeyBanc
KeyBanc analyst Brandon Nispel raised his price for SBA Communications (SBAC) to $195 from $183.97 and reiterated an Overweight rating on the shares. The analyst believes that if the T-Mobile (TMUS)/Sprint (S) merger goes through, 2020 should be another year of growth acceleration.
02/28/19
BTIG
02/28/19
NO CHANGE
Target $60
BTIG
Buy
SoftBank price target raised to $60 from $50 at BTIG
BTIG analyst Walter Piecyk raised his price target on SoftBank (SFTBY) to $60 and kept his Buy rating, citing his "better understanding" of the previously acquired ARM Holdings business which warrants a higher multiple. The analyst also sees a major catalyst coming in the "imminent decision" around Sprint (S) / T-Mobile (TMUS) deal, which could amount to additional $14 price target impact on Softbank shares.
TMUS T-Mobile
$71.00

-2.8 (-3.79%)

NTRA Natera
$20.00

-0.27 (-1.33%)

03/11/19
PIPR
03/11/19
NO CHANGE
Target $23
PIPR
Overweight
Natera partnership removes financing risk through 2020, says Piper Jaffray
Piper Jaffray analyst William Quirk says he likes the "non-dilutive funding" from Natera's 10-year partnership agreement with BGI Genomics and believes the deal removes the company's financing risk through at least 2020. Further, BGI is a major sequencing provider in China and this deal immediately expands Natera's access to this large market, Quirk tells investors in a research note. This "looks like a smart deal for both parties," says Quirk, who reiterates an Overweight rating on Natera with a $23 price target.
04/04/19
BARD
04/04/19
NO CHANGE
Target $24
BARD
Outperform
Natera remains 'top idea' following management meetings, says Baird
Baird analyst Catherine Ramsey Schulte maintained an Outperform rating and $24 price target on Natera, saying she continues to recommend Natera as a top idea following recent investor meetings with CEO Steve Chapman and CFO Mike Brophy. The analyst thinks Natera's core business is healthy and believes transplant and oncology opportunities are only partially valued in the stock today and could drive meaningful upside over the next few years.
03/28/19
RAJA
03/28/19
NO CHANGE
RAJA
Strong Buy
CareDx lawsuit against Natera 'not unexpected,' says Raymond James
Raymond James analyst John Hsu notes that CareDx (CDNA) announced the filing of a patent infringement lawsuit against Natera (NTRA), which was "not unexpected." The analyst sees the lawsuit as consistent with management seeking to protect the company's intellectual property, and notes that the court process could take up to three years. While this lawsuit is a "logical course of action," Hsu believes CareDx remains focused on building its moat in kidney transplant, with sales force investments and a focus on integration with hospital electronic medical records. Overall, the analyst still views 2019's main focus on other activities to strengthen a "significant head start on the back of a best-in-class product launch in 2018." He reiterates a Strong Buy rating on CareDx shares.
03/29/19
ADAM
03/29/19
NO CHANGE
Target $27
ADAM
Buy
Natera draft local coverage decision a 'positive surprise,' says Canaccord
Canaccord analyst Mark Massaro said he was positively surprised that Natera was issued a draft local coverage decision by Palmetto MolDx for its blood-based kidney transplant rejection test, as he sees the news increasing the probability that the test launches with Medicare reimbursement. Even after yesterday's move higher on this news, Natera shares trade at a "material disconnect" to what the business is actually worth, Massaro contends. He raised his price target on the stock to $27 from $26 and keeps a Buy rating on Natera, adding that the stock "is at the top of our list of top picks for 2019."
ARNC Arconic
$20.56

0.02 (0.10%)

12/20/18
LBOW
12/20/18
UPGRADE
LBOW
Buy
Arconic upgraded to Buy from Neutral at Longbow
01/14/19
JPMS
01/14/19
DOWNGRADE
Target $22
JPMS
Neutral
Arconic downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Gambardella downgraded Arconic (ARNC) to Neutral and lowered his price target for the shares to $22 from $24. The analyst cites valuation for the downgrade. The shares are gradually pricing in a buyout, which is appropriate, Gambardella tells investors in a research note. Bloomberg on January 2 reported that Apollo Global (APO) in talks to buy Arconic for $22 per share.
12/20/18
12/20/18
UPGRADE
Target $24

Buy
Longbow upgrades Arconic to Buy after positive aerospace supplier survey
As previously reported, Longbow analyst Chris Olin upgraded Arconic to Buy from Neutral, stating that his survey of contacts in the tier-3 and tier-4 aerospace channel reported an accelerating top-line growth environment. Some smaller aerospace forging competitors are now facing constrained production capacity, which he believes could protect Arconic's aerospace & defense market share, Olin added. He also believes take-out speculation "offers a solid trading floor in the mid-$17/share range," the analyst tells investors. He set a $24 price target on Arconic shares.
01/14/19
01/14/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Delta Air Lines (DAL) downgraded to Neutral from Buy at BofA/Merrill with analyst Andrew Didora saying his Flight Indicator data analysis suggests a "deceleration in domestic PRASM" in the first half of the year, coupled with other slowing demand indicators that include "weak ISM survey, declining CEO Confidence, airline pricing growth off highs, currency headwind, and government shutdown." 2. Illinois Tool Works (ITW) downgraded to Neutral from Buy at Citi with analyst Andrew Kaplowtiz saying the company's "overexposure" to "slowing" Europe is a risk. 3. Chevron (CVX) downgraded to Hold from Buy at HSBC with analyst Gordon Gray saying the scale of U.S. supply, and its responsiveness to any significant hike in price, will likely limit the price upside for crude. 4. Arconic (ARNC) downgraded to Neutral from Overweight at JPMorgan with analyst Michael Gambardella citing valuation. 5. XPO Logistics (XPO) downgraded to Sector Weight from Overweight at KeyBanc with analyst Todd Fowler citing his view that the big and bulky final mile market is increasingly competitive, along with ongoing uncertainty around European end markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SGEN

Seattle Genetics

$71.10

1.69 (2.43%)

21:00
04/25/19
04/25
21:00
04/25/19
21:00
Recommendations
Seattle Genetics analyst commentary at Piper Jaffray »

Seattle Genetics Q1 marks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

  • 31

    May

  • 06

    Jun

TCBK

TriCo Bancshares

$39.57

-0.47 (-1.17%)

20:35
04/25/19
04/25
20:35
04/25/19
20:35
Earnings
TriCo Bancshares reports Q1 EPS 74c, consensus 71c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

XOM

Exxon Mobil

$82.25

0.51 (0.62%)

, CVX

Chevron

$117.93

-0.38 (-0.32%)

20:25
04/25/19
04/25
20:25
04/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

XOM

Exxon Mobil

$82.25

0.51 (0.62%)

CVX

Chevron

$117.93

-0.38 (-0.32%)

CL

Colgate-Palmolive

$68.64

-0.2 (-0.29%)

ADM

Archer Daniels

$41.77

-0.99 (-2.32%)

WY

Weyerhaeuser

$26.27

-0.07 (-0.27%)

AAL

American Airlines

$33.36

-0.64 (-1.88%)

LEA

Lear

$146.64

-6.455 (-4.22%)

IPG

Interpublic Group

$22.28

-0.26 (-1.15%)

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

AN

AutoNation

$39.43

0.91 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 30

    Apr

  • 01

    May

  • 08

    May

  • 10

    May

  • 16

    May

  • 17

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 29

    May

  • 04

    Jun

  • 12

    Jun

  • 13

    Nov

ATRC

AtriCure

$28.19

0.21 (0.75%)

20:18
04/25/19
04/25
20:18
04/25/19
20:18
Recommendations
AtriCure analyst commentary at Piper Jaffray »

AtriCure growth story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 22

    May

NOW

ServiceNow

$260.95

18.54 (7.65%)

19:43
04/25/19
04/25
19:43
04/25/19
19:43
Recommendations
ServiceNow analyst commentary at Jefferies »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

GFI

Gold Fields

$3.74

0.08 (2.19%)

19:34
04/25/19
04/25
19:34
04/25/19
19:34
Upgrade
Gold Fields rating change at BMO Capital »

Gold Fields upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

19:28
04/25/19
04/25
19:28
04/25/19
19:28
Hot Stocks
Watchdog finds at least 78,000 reviews removed from Amazon »

Watchdog Which? said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

EHTH

eHealth

$62.23

0.32 (0.52%)

, MAT

Mattel

$12.30

-0.25 (-1.99%)

19:02
04/25/19
04/25
19:02
04/25/19
19:02
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

EHTH

eHealth

$62.23

0.32 (0.52%)

MAT

Mattel

$12.30

-0.25 (-1.99%)

KNL

Knoll

$20.57

-0.22 (-1.06%)

GRUB

GrubHub

$69.83

0.53 (0.76%)

PRO

Pros Holdings

$45.06

-0.25 (-0.55%)

F

Ford

$9.41

-0.17 (-1.77%)

COF

Capital One

$88.09

0.3 (0.34%)

SFLY

Shutterfly

$42.30

-0.65 (-1.51%)

COLM

Columbia Sportswear

$104.45

-0.65 (-0.62%)

SWN

Southwestern Energy

$4.03

-0.13 (-3.13%)

DFS

Discover

$77.48

0.43 (0.56%)

LOGM

LogMeln

$84.32

0.085 (0.10%)

BABY

Natus Medical

$25.20

0.54 (2.19%)

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

SBUX

Starbucks

$77.07

0.65 (0.85%)

ATEN

A10 Networks

$7.28

0.14 (1.96%)

PFPT

Proofpoint

$131.35

3.56 (2.79%)

FII

Federated Investors

$33.57

0.605 (1.84%)

INTC

Intel

$57.59

-1.13 (-1.92%)

BEAT

BioTelemetry

$59.26

0.52 (0.89%)

BGG

Briggs & Stratton

$13.61

-0.44 (-3.13%)

SKYW

SkyWest

$58.44

-1.31 (-2.19%)

SGEN

Seattle Genetics

$71.10

1.69 (2.43%)

VCRA

Vocera

$31.31

0.36 (1.16%)

ILMN

Illumina

$318.91

4.47 (1.42%)

INT

World Fuel Services

$31.15

0.1 (0.32%)

BMRN

BioMarin

$85.40

-0.06 (-0.07%)

MHK

Mohawk

$130.69

-3.46 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 28

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 20

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 24

    Jul

  • 06

    Aug

  • 03

    Sep

  • 23

    Oct

  • 13

    Nov

ATEN

A10 Networks

$7.28

0.14 (1.96%)

19:00
04/25/19
04/25
19:00
04/25/19
19:00
Earnings
A10 Networks sees Q2 EPS (8c) to 0c, two estimates 0c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ATEN

A10 Networks

$7.28

0.14 (1.96%)

18:59
04/25/19
04/25
18:59
04/25/19
18:59
Earnings
A10 Networks reports Q1 EPS (9c), two estimates (7c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CNC

Centene

$50.20

0.04 (0.08%)

18:44
04/25/19
04/25
18:44
04/25/19
18:44
Hot Stocks
Centene CEO: Most people are happy with their healthcare »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

  • 23

    Jul

APHA

Aphria

$7.64

-0.17 (-2.18%)

18:23
04/25/19
04/25
18:23
04/25/19
18:23
Hot Stocks
Green Growth Brands says offer for Aphria has expired »

Green Growth Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$296.77

-0.35 (-0.12%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Hot Stocks
Align Technology CEO: We are enjoying good growth in North America »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 05

    Jun

AAPL

Apple

$205.28

-1.82 (-0.88%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Periodicals
Several veterans leave Apple's design team, WSJ reports »

Apple's design team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:18
04/25/19
04/25
18:18
04/25/19
18:18
Hot Stocks
Canadian agency says probe shows Facebook broke privacy law »

Canada's Office of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

NOV

National Oilwell

$26.44

-0.04 (-0.15%)

18:17
04/25/19
04/25
18:17
04/25/19
18:17
Earnings
National Oilwell reports Q1 EPS (20c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 22

    May

  • 13

    Nov

FB

Facebook

$193.23

10.59 (5.80%)

18:16
04/25/19
04/25
18:16
04/25/19
18:16
Hot Stocks
Ireland's DPC opens statutory inquiry into Facebook »

Ireland's Data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:15
04/25/19
04/25
18:15
04/25/19
18:15
Hot Stocks
NY AG to investigate Facebook's collection of user email contact databases »

New York State Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

18:09
04/25/19
04/25
18:09
04/25/19
18:09
Hot Stocks
Amazon.com says had 'a lot of good customer wins' in Q1 »

Says: Usage growth higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

FIBK

First Interstate

$41.94

-0.63 (-1.48%)

18:08
04/25/19
04/25
18:08
04/25/19
18:08
Earnings
First Interstate reports Q1 EPS 69c, consensus 72c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

F

Ford

$9.41

-0.17 (-1.77%)

18:03
04/25/19
04/25
18:03
04/25/19
18:03
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says improving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

PUB

People's Utah Bancorp

$28.02

0.09 (0.32%)

18:01
04/25/19
04/25
18:01
04/25/19
18:01
Earnings
People's Utah Bancorp reports Q1 EPS ,55c consensus 55c »

Reports Q1 NII $26.91M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 15

    May

AEGN

Aegion

$19.44

-0.58 (-2.90%)

17:57
04/25/19
04/25
17:57
04/25/19
17:57
Hot Stocks
Aegion subsidiary awarded three contracts valued at $13M total »

Aegion announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

17:55
04/25/19
04/25
17:55
04/25/19
17:55
Hot Stocks
Amazon.com says will spend $800M in Q2 to move to one-day Prime delivery »

Says: Need to build out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

F

Ford

$9.41

-0.17 (-1.77%)

17:53
04/25/19
04/25
17:53
04/25/19
17:53
Hot Stocks
Ford CFO: Encouraged by progress made in China toward return to profitability »

Sees FY19 revenue growth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.